Jain Sarika, Gaind Rajni, Kothari Charu, Sehgal Rachna, Shamweel A, Thukral S S, Chellani Harish K
Department of Microbiology, VMMC and Safdarjang Hospital , New Delhi 110029 , India.
Department of Pediatrics, VMMC and Safdarjang Hospital , New Delhi 110029 , India.
JMM Case Rep. 2016 Aug 30;3(4):e005056. doi: 10.1099/jmmcr.0.005056. eCollection 2016 Aug.
Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, multidrug-resistant (MDR) pathogens, are increasingly implicated in nosocomial outbreaksworldwide, particularly in neonatal intensive care units (NICUs). is an uncommon nosocomial pathogen causing sepsis in neonates.
We report an outbreak of ESBL-positive MDR sepsis involving five babies within 10 days in a NICU, which was promptly detected and managed. The aim of this study was to characterize the molecular mechanism of resistance to third-generation cephalosporins (3GCs) in the bacteria. Surveillance cultures were collected from health-care personnel (hand swabs, urine) and the surrounding patient-care environment. Ribotyping was performed to determine the clonality of the strain. Thirteen were recovered from the blood cultures of the five babies and surveillance cultures. Twelve isolates were positive for the VEB-1 ESBL type, and were susceptible only to ciprofloxacin and carbapenems. There was an unusual phenotypic synergy observed between the 3GCs and imipenem/cefoxitin. The source of infection was traced to a contaminated multidose vial. The outbreak was associated with a high mortality (80 %). A change of empirical antibiotic policy to ciprofloxacin, with strict infection control measures, brought the outbreak to an abrupt end.
This is believed to be the first report of a nosocomial outbreak of VEB-1 ESBL-producing sepsis in neonates from India. The present report of infection due to VEB-1-producing , an uncommon pathogen for an epidemic in a neonatal unit, highlights the growing significance of such Gram-negative bacteria as a cause of infections in newborns. Epidemic spread in a neonatal unit of an ESBL-producing species, which also had an intrinsically reduced susceptibility to imipenem, and resistance to colistin and tigecycline, can be a threatening situation and can result in high neonatal mortality unless recognized and controlled in a timely manner.
产超广谱β-内酰胺酶(ESBL)的肠杆菌科细菌是多重耐药病原体,在全球医院感染暴发中,尤其是在新生儿重症监护病房(NICU)中,其作用日益显著。是一种在新生儿中引起败血症的不常见医院病原体。
我们报告了一家新生儿重症监护病房在10天内发生的一起产ESBL阳性多重耐药败血症暴发事件,涉及5名婴儿,该事件被及时发现并得到处理。本研究的目的是确定该细菌对第三代头孢菌素(3GCs)耐药的分子机制。从医护人员(手部拭子、尿液)和周围患者护理环境中采集监测培养物。进行核糖体分型以确定菌株的克隆性。从5名婴儿的血培养物和监测培养物中分离出13株。12株分离株VEB-1型ESBL呈阳性,仅对环丙沙星和碳青霉烯类敏感。在3GCs与亚胺培南/头孢西丁之间观察到一种不寻常的表型协同作用。感染源追溯到一个被污染的多剂量瓶。此次暴发与高死亡率(80%)相关。将经验性抗生素策略改为环丙沙星,并采取严格的感染控制措施,使暴发突然结束。
据信这是印度首次关于新生儿中由产VEB-1 ESBL败血症引起医院感染暴发的报告。本报告中,作为新生儿病房流行的一种不常见病原体,产VEB-1败血症感染突出了此类革兰氏阴性菌作为新生儿感染病因的重要性日益增加。在新生儿病房中,一种产ESBL菌种的流行传播,该菌种对亚胺培南本身敏感性降低,且对黏菌素和替加环素耐药,可能是一种威胁性情况,除非及时识别和控制,否则可能导致高新生儿死亡率。